Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
7.38
-0.59 (-7.40%)
Nov 20, 2024, 4:00 PM EST - Market closed

Addex Therapeutics Statistics

Total Valuation

ADXN has a market cap or net worth of $6.64 million. The enterprise value is $2.40 million.

Market Cap 6.64M
Enterprise Value 2.40M

Important Dates

The next confirmed earnings date is Friday, November 22, 2024, before market open.

Earnings Date Nov 22, 2024
Ex-Dividend Date n/a

Share Statistics

ADXN has 98.30 million shares outstanding. The number of shares has increased by 50.83% in one year.

Current Share Class n/a
Shares Outstanding 98.30M
Shares Change (YoY) +50.83%
Shares Change (QoQ) +72.24%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 34.24M

Valuation Ratios

The trailing PE ratio is 1.38.

PE Ratio 1.38
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio n/a
P/TBV Ratio 0.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.50
EV / Sales 2.50
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.97, with a Debt / Equity ratio of 0.00.

Current Ratio 4.97
Quick Ratio 4.67
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -513.81

Financial Efficiency

Return on equity (ROE) is -126.29% and return on invested capital (ROIC) is -73.55%.

Return on Equity (ROE) -126.29%
Return on Assets (ROA) -61.71%
Return on Capital (ROIC) -73.55%
Revenue Per Employee $41,767
Profits Per Employee $208,904
Employee Count 23
Asset Turnover 0.08
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +23.00% in the last 52 weeks. The beta is 1.87, so ADXN's price volatility has been higher than the market average.

Beta (5Y) 1.87
52-Week Price Change +23.00%
50-Day Moving Average 9.95
200-Day Moving Average 10.47
Relative Strength Index (RSI) 28.14
Average Volume (20 Days) 58,175

Short Selling Information

Short Interest 3,461
Short Previous Month 9,886
Short % of Shares Out 0.41%
Short % of Float n/a
Short Ratio (days to cover) 0.14

Income Statement

In the last 12 months, ADXN had revenue of $960,641 and earned $4.80 million in profits. Earnings per share was $0.05.

Revenue 960,641
Gross Profit -6.80M
Operating Income -12.47M
Pretax Income -12.96M
Net Income 4.80M
EBITDA -12.32M
EBIT -12.47M
Earnings Per Share (EPS) $0.05
Full Income Statement

Balance Sheet

The company has $4.22 million in cash and $35,813 in debt, giving a net cash position of $4.18 million or $0.04 per share.

Cash & Cash Equivalents 4.22M
Total Debt 35,813
Net Cash 4.18M
Net Cash Per Share $0.04
Equity (Book Value) 14.08M
Book Value Per Share 0.14
Working Capital 4.17M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$8.71 million and capital expenditures -$2,095, giving a free cash flow of -$8.86 million.

Operating Cash Flow -8.71M
Capital Expenditures -2,095
Free Cash Flow -8.86M
FCF Per Share -$0.09
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -1,298.01%
Pretax Margin -1,373.53%
Profit Margin 500.17%
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin -576.02%

Dividends & Yields

ADXN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -50.83%
Shareholder Yield -50.83%
Earnings Yield 72.37%
FCF Yield -133.45%

Analyst Forecast

The average price target for ADXN is $30.00, which is 306.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target $30.00
Price Target Difference 306.50%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 23, 2023. It was a reverse split with a ratio of 0.05:1.

Last Split Date Oct 23, 2023
Split Type Reverse
Split Ratio 0.05:1

Scores

ADXN has an Altman Z-Score of -32.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -32.87
Piotroski F-Score 2